Andre Lapierre (Ph.D., chemistry) is a Scientist at Goodmans.
He collaborates with his colleagues in the Litigation and Dispute Resolution Group in the pharmaceutical area, using his technical background to advance clients’ cases.
Recent cases where successful outcomes for the client were achieved include:
Takeda v. Apotex, 2024 FC 106 - successful challenge to the validity of a patent relating to preventing excessive gastric acidity (dexlansoprazole), on the basis of a lack of utility
Janssen v. Apotex, 2021 FC 7 - successful challenge to the validity of a patent relating to a prostate cancer medication (abiraterone), on the bases of obviousness
Eli Lilly v. Apotex, 2020 FC 814 – successful challenge to the validity and infringement of a patent relating to the process to make the active ingredient in an ED medication (tadalafil), on the bases of anticipation and obviousness
Takeda Canada v. Apotex, 2015 FC 570 - successful challenge to the validity of a patent relating to an allergic rhinitis medication (ciclesonide), on the bases of obviousness
Alcon Canada v. Apotex, 2014 FC 791 - successful challenge to the validity of a patent relating to the formulation of a glaucoma medication (travoprost), on the basis of obviousness
Alcon Canada v. Apotex, 2014 FC 699 - successful challenge to the validity of a patent relating to a glaucoma medication (travoprost), on the bases of anticipation and obviousness
